Home / Taiwan Excellence Award / Award Winning Products / Product Details

Intelligent healthcare system: rightest care total solution
Industry type:Health and precision instrument
Product model number:Rightest CARE Total Solution System
Bionime Corporation
award 3

Rightest CARE is an extended product from Bluetooth glucose meter. Through mobile phone auto syncing, it collects complete glucose data. With its big data analysis and artificial intelligence, it provides exact innovation and changes to satisfy the desire of both diabetes patients and medical professionals. Furthermore, the solution matches strict personal data protection regulations around the world.
Today, it is the only one solution which provides mutual way data communication between the patients, the family and medical professionals, allowing all stakeholders to link with one another in the loop. At the end of the day, diabetes patients need not only a mobile app to record their glucose data, but an everyday partner who can fit in their daily lives and walk them through the difficulties they have been facing with diabetes.

Contact online

About Bionime Corporation

Established in 2003, Bionime has pioneered with its brand "RIGHTEST", independently developing, designing, producing, and marketing a range of products including traditional glucose monitors and specialized hospital systems. In 2023, it became the first CGM medical device manufacturer in Taiwan approved by the Ministry of Health and Welfare. Beyond glucose management, Bionime has developed a digital ecosystem centered around users with its IoT technology team. This includes the RIGHTEST iFree CGM App, which provides real-time glucose data and dynamic curves for lifestyle improvement, and a Diabetes Management System (DMS) for healthcare providers, enhancing patient care. Additionally, the RIGHTEST Partner App allows caregivers real-time access to patient data. Aiming to be among the top global providers, Bionime’s products span various technologies and patents, with automated production systems recognized for reaching industrial 4.0 standards.

http://tw.bionime.com/

Bionime, founded in 2003, specializes in custom blood glucose monitoring systems for diabetics, internationally recognized for accuracy under its brand "RIGHTEST". Its systems, including personal (BGM and CGM) and medical (POCT) glucose management, are enhanced by an IoT-enabled app linking patients, families, and medical teams. Bionime focuses on quality and innovation, maintaining automated production for control and efficiency, holding over 400 global patents. As a leading Taiwanese brand, Rightest enhances public health with reliable products and simplifies glucose tracking for users and caregivers. It is the first in Taiwan approved by the Ministry of Health and Welfare in October 2023 for manufacturing CGM medical devices. Bionime's vertical integration strategy ensures the affordability and accessibility of its advanced CGM systems.